Development of QbD Driven liquid chromatographic Method for Quantification of Molnupiravir API Capsule Formulation
International Journal of Drug Delivery Technology · 08.04.2026 · 16 (03)
DOI: 10.25258/ijddt.16.3.75 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.04.2026. Verfasst von V.U. Barge und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Molnupiravir is an antiviral drug used to treat moderate-to-severe Coronavirus Disease-2019 (COVID-19) infection. The current research article presents a novel method that applies the principle of quality by design (QbD) to the development of a robust High Performance Liquid Chromatography (HPLC) method for estimating Molnupiravir in Active Pharmaceutical Ingredient (API) and its capsule formulation. Using this QbD concept, we have defined the Quality Target Method Profile (QTMP), identified Critical Quality Attributes (CQA), including Critical Analytical Attributes (CAA), Critical Material Attributes (CMA), and applied risk assessment to optimize CMA. Through Central Composite Design (CCD), a design space was obtained, ensuring the robustness of the proposed method. Mobile phase of the developed method was optimized to 80:20 ratio for Water: ACN (Acetonitrile) with flow rate of 1.0 ml/min, measured at 235 nm wavelength. The chromatographic run time of the proposed analytical method is 10 minutes. The optimized HPLC method was validated as per the International Council of Hormonisation (ICH) Q2 (R1) guidelines. The study highlights the effectiveness of QbD strategy in achieving a reliable and optimized liquid chromatographic method for Molnupiravir quantification.
Zitieren
APA
Barge, V., & Bhalerao, R. (2026). Development of QbD Driven liquid chromatographic Method for Quantification of Molnupiravir API Capsule Formulation. International Journal of Drug Delivery Technology, 16(03). https://doi.org/10.25258/ijddt.16.3.75
Vancouver
Barge V, Bhalerao R. Development of QbD Driven liquid chromatographic Method for Quantification of Molnupiravir API Capsule Formulation. International Journal of Drug Delivery Technology. 2026;16(03). doi:10.25258/ijddt.16.3.75
BibTeX
@article{Barge2026,
author = {Barge, V.U. and Bhalerao, R.A.},
title = {Development of QbD Driven liquid chromatographic Method for Quantification of Molnupiravir API Capsule Formulation},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {03},
doi = {10.25258/ijddt.16.3.75}
}
EUVIMED